BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 17468833)

  • 1. Ciliary body melanoma with limited nodular extrascleral extension and diffuse iris-angle infiltration treated by whole anterior segment plaque radiotherapy.
    Gray ME; Corrêa ZM; Augsburger JJ; Barrett W
    Int Ophthalmol; 2007 Aug; 27(4):273-6. PubMed ID: 17468833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque radiotherapy for choroidal and ciliochoroidal melanomas with limited nodular extrascleral extension.
    Augsburger JJ; Schneider S; Narayana A; Breneman JC; Aron BS; Barrett WL; Trichopoulos N
    Can J Ophthalmol; 2004 Jun; 39(4):380-7. PubMed ID: 15327103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
    Finger PT
    Am J Ophthalmol; 2001 Sep; 132(3):328-35. PubMed ID: 11530044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
    Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
    Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of treated ciliary body melanoma following trabeculectomy.
    Tay E; Cree IA; Hungerford J; Franks W
    Clin Exp Ophthalmol; 2009 Jul; 37(5):503-5. PubMed ID: 19624348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palladium-103 plaque radiation therapy for ciliary body melanoma through a functioning glaucoma filtering bleb.
    Pathan AHK; Barash A; Tena LB; Finger PT
    Eur J Ophthalmol; 2018 Jan; 28(1):119-122. PubMed ID: 28967074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
    Gündüz K; Shields CL; Shields JA; Cater J; Brady L
    Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
    Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse Anterior Retinoblastoma with Globe Salvage and Visual Preservation in 3 Consecutive Cases.
    Shields CL; Lally SE; Manjandavida FP; Leahey AM; Shields JA
    Ophthalmology; 2016 Feb; 123(2):378-384. PubMed ID: 26522706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
    Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
    Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound biomicroscopy features of iris and ciliary body melanomas before and after brachytherapy.
    Torres VL; Allemann N; Erwenne CM
    Ophthalmic Surg Lasers Imaging; 2005; 36(2):129-38. PubMed ID: 15792314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anterior uveal malignant melanoma with subconjunctival extension--a clinical case].
    Dragne C; Filip M; Magureanu M; Nicodin A
    Oftalmologia; 2005; 49(1):22-5. PubMed ID: 15934332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7diffuse melanotic lesion of the iris as a presenting feature of ciliary body melanocytoma: report of a case and review of the literature.
    Biswas J; D'Souza C; Shanmugam MP
    Surv Ophthalmol; 1998; 42(4):378-82. PubMed ID: 9493281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Block excision of tumors of the anterior uvea. Report on 68 consecutive patients.
    Naumann GO; Rummelt V
    Ophthalmology; 1996 Dec; 103(12):2017-27; discussion 2027-8. PubMed ID: 9003335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uveal malignant melanoma with extrascleral extension, treated with plaque radiotherapy.
    Muen WJ; Damato BE
    Eye (Lond); 2007 Feb; 21(2):307-8. PubMed ID: 16946742
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pigmented ciliary body tumours: benign or malignant?].
    Vallejo-Vicente E; Saornil-Álvarez MA; López-Lara F; García-Álvarez C; de Frutos-Baraja JM; Díez-Andino P
    Arch Soc Esp Oftalmol; 2013 Dec; 88(12):485-8. PubMed ID: 24257259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium-106 brachytherapy for iris and iridociliary melanomas.
    Marinkovic M; Horeweg N; Laman MS; Bleeker JC; Ketelaars M; Peters FP; Luyten GPM; Creutzberg CL
    Br J Ophthalmol; 2018 Aug; 102(8):1154-1159. PubMed ID: 29122824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
    Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of ciliary body melanoma with iodine-125 plaque brachytherapy.
    Krema H; Simpson ER; Pavlin CJ; Payne D; Vasquez LM; McGowan H
    Can J Ophthalmol; 2009 Aug; 44(4):395-400. PubMed ID: 19606159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.
    Shields CL; Naseripour M; Shields JA; Freire J; Cater J
    Am J Ophthalmol; 2003 May; 135(5):648-56. PubMed ID: 12719072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.